Literature DB >> 213389

Protective effect of early serum from mice after cytomegalovirus infection.

T P Araullo-Cruz, M Ho, J A Armstrong.   

Abstract

Serum obtained from mice 3 to 5 days after cytomegalovirus infection contained complement-requiring neutralizing antibody, which, when passively transferred, protected mice from lethal infection with the homologous virus. The active substance was largely heat-stable 7s immunoglobulin.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 213389      PMCID： PMC422073          DOI： 10.1128/iai.21.3.840-842.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  9 in total

1.  STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. I. APPEARANCE OF NEUTRALIZING ANTIBODIES HAVING DIFFERENT GRADES OF COMPLEMENT REQUIREMENT.

Authors:  K YOSHINO; S TANIGUCHI
Journal:  Virology       Date:  1965-05       Impact factor: 3.616

2.  Mouse salivary gland virus infections.

Authors:  A MANNINI; D N MEDEARIS
Journal:  Am J Hyg       Date:  1961-05

3.  Production of interferon and serum hyporeactivity factor in mice infected with murine cytomegalovirus.

Authors:  G C Tarr; J A Armstrong; M Ho
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Cytomegalovirus-induced immune suppression. I. Humoral immunity.

Authors:  R J Howard; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

6.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

7.  A new overlay for plaquing animal viruses.

Authors:  H Mirchamsy; F Rapp
Journal:  Proc Soc Exp Biol Med       Date:  1968-10

8.  Immunosuppression during acute murine cytomegalovirus infection.

Authors:  J E Osborn; A A Blazkovec; D L Walker
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

9.  Role of T lymphocytes in recovery from murine cytomegalovirus infection.

Authors:  S E Starr; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441
  9 in total
  18 in total

Review 1.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 3.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement.

Authors:  Y Eizuru; I Ueno; Y Minamishima
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Murine cytomegalovirus infection in the spleen and its relationship to immunosuppression.

Authors:  L Loh; J B Hudson
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Murine cytomegalovirus-induced immunosuppression.

Authors:  L Loh; J B Hudson
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.

Authors:  Nikolaus Wirtz; Sina I Schader; Rafaela Holtappels; Christian O Simon; Niels A W Lemmermann; Matthias J Reddehase; Jürgen Podlech
Journal:  Med Microbiol Immunol       Date:  2008-03-26       Impact factor: 3.402

8.  Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

Authors:  M Ho
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

9.  Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity.

Authors:  C M Lawson; H L O'Donoghue; H E Farrell; G R Shellam; W D Reed
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

10.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.